James Frey
Education
The Wharton School
MBA, Business 1996-08-01 - 1998-05-01
Kenyon College
BA, Biology 1987-08-01 - 1991-05-01Work Experience
Ipsen
Current
Ipsen
Wawa, Inc.
2019-11-01 - 2024-06-01
Wawa, Inc.
Pfizer
1999-06-01 - 2018-05-01
Pfizer
Booz Allen & Hamilton, Inc
1998-07-01 - 1999-06-01
Booz Allen & Hamilton, Inc
Biogen
1994-03-01 - 1996-07-01
Biogen
Alkermes
1992-07-01 - 1994-03-01
Alkermes
Whitehead Institute
1991-07-01 - 1992-07-01
Whitehead Institute
Skills
Summary
With more than 20 years of experience in marketing leadership roles across the global pharmaceutical sector, I have a demonstrated track record of consistently outperforming targets, delivering top-line growth and profitability, rapidly launching new products and therapies, and forging mission-critical partnerships and alliances worldwide. As Commercial Lead for Bevacizumab at Pfizer, I laid the foundation to achieve $143M in revenues versus a target of $100M, with sales expected to peak at $800M. As Global Head of Marketing for Chantix at Pfizer, I achieved $883M in global sales, representing 80% of the drug’s peak sales forecast within the 1st year of launch versus an industry average of 20%. As Director of Marketing at Pfizer, I developed a $33M grant program, earning Pfizer recognition as the 3rd largest funder of tobacco control initiatives (behind the Gates Foundation and Bloomberg Philanthropies) and played a key role in awarding grants to 15 NGOs in 26 countries across the developing world. And as Senior Marketing Manager at Pfizer, I achieved $300M in 1st year revenues for Caduet without cannibalizing sales of either Norvasc or Lipitor.
